Strategic Forecast for the In Vitro Diagnostics Industry: Market Outlook 2025-2034

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

In Vitro Diagnostics Market Size Growth Forecast: What to Expect by 2025?
The market size of in-vitro diagnostics has been expanding swiftly in the past few years. A rise from $130.74 billion in 2024 to $149.01 billion in 2025 is anticipated, marking a compound annual growth rate (CAGR) of 14.0%. Factors driving growth during historical periods include advancements in automated analyzers and molecular diagnostics, an aging population, disease epidemics, healthcare regulations, and the rise of personalized medicine.

How Will the In Vitro Diagnostics Market Size Evolve and Grow by 2029?
Expectations suggest a significant surge in the size of the in-vitro diagnostics market over the coming years. The predicted size of the market is estimated to reach $232.69 billion by 2029, expanding at a compound annual growth rate (CAGR) of 11.8%. This anticipated growth during the estimation period can be ascribed to factors such as precision medicine, point-of-care testing, the rise of digital health and data analysis capabilities, and preparedness for potential pandemics. Notable upcoming trends within this period comprise technological enhancements, integration of digital health, customization of diagnostics, the advent of home testing kits, and developments in molecular diagnostics.

View the full report here:
https://www.thebusinessresearchcompany.com/report/in-vitro-diagnostics-global-market-report

What Drivers Are Propelling the Growth of In Vitro Diagnostics Market Forward?
The increasing preference for self-conducted test kits is projected to fuel the expansion of the in vitro diagnostics market. Self-conducted test kits denote medicinal or diagnostic apparatuses intended for personal use without the necessity of a medical expert or skilled staff for home-based testing. These self-conducted test kits improve access by allowing people to execute diagnostic evaluations at their residences, providing convenience and potentially boosting the desire for testing, especially for conditions that have not been diagnosed before. For example, the Centers for Disease Control and Prevention, an American public health organization, confirmed that there was a prominent surge in the utilization of home-based COVID-19 tests amid US adults aged 18 and above from the Delta-dominant span (August to December 2021) to the Omicron-dominant span (December to March 2022) in April 2022. The application of at-home tests among respondents who experienced COVID-19-like symptoms grew from 5.7% to 20.1%. Hence, the growing popularity of self-conducted test kits will bolster the expansion of the in vitro diagnostics market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=13065&type=smp

Which Emerging Trends Are Transforming the In Vitro Diagnostics Market in 2025?
In an effort to enhance their profitability, primary businesses in the in vitro diagnostics market are concentrating their efforts on creating innovative products, such as the Cobas pulse system. This product is a professional solution for managing blood glucose, fortified with mobile digital health features to elevate patient care. Roche Diagnostics, a US-based firm specializing in advancing unique products and services addressing disease prevention, diagnosis, monitoring, screening, and treatment, introduced the Cobas pulse system in January 2022. This portable device, with an automated glucose test strip reader, a camera, and a touchscreen to gather extra diagnostic information, is user-friendly. It is crafted for seamless utilization, boasting handy features that streamline operations, conserve time, and boost work processes.

What Are the Key Segments in the In Vitro Diagnostics Market?
The in vitro diagnostics market covered in this report is segmented -

1) By Type: Point-of-Care Diagnostics Devices And Equipment, Immunochemistry Diagnostic Devices And Equipment, Clinical Chemistry Diagnostics Devices And Equipment, Molecular Diagnostics Devices And Equipment, Microbiology Diagnostic Devices And Equipment, Hemostasis Diagnostic Devices And Equipment, Hematology Diagnostic Devices And Equipment, Immunohematology Diagnostic Devices And Equipment
2) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users
3) By Type of Expenditure: Public, Private
4) By Product: Instruments/Equipment, Disposables

Subsegments:
1) By Point-Of-Care Diagnostics Devices And Equipment: Blood Glucose Monitoring, Pregnancy And Fertility Testing, Infectious Disease Testing, Cardiac Markers Testing, Coagulation Testing
2) By Immunochemistry Diagnostic Devices And Equipment: Enzyme-Linked Immunosorbent Assay (ELISA), Radioimmunoassay (RIA), Western Blot, Immunofluorescence Assay, Chemiluminescence Immunoassay (CLIA)
3) By Clinical Chemistry Diagnostic Devices And Equipment: Blood Glucose Testing, Cholesterol Testing, Liver Function Testing, Kidney Function Testing, Electrolyte Testing
4) By Molecular Diagnostics Devices And Equipment: PCR (Polymerase Chain Reaction) Instruments, Next-Generation Sequencing (NGS) Instruments, Microarray Instruments, FISH (Fluorescence In Situ Hybridization) Devices
5) By Microbiology Diagnostic Devices And Equipment: Microbial Culture Systems, Automated Identification Systems, Antimicrobial Susceptibility Testing Systems, Blood Culture Systems
6) By Hemostasis Diagnostic Devices and Equipment: Coagulation Analyzers, Thromboelastography Systems, Platelet Function Analyzers, Clotting Factor Analyzers
7) By Hematology Diagnostic Devices and Equipment: Hematology Analyzers, Hemoglobin Testing Systems, Complete Blood Count (CBC) Devices, Blood Cell Counters
8) By Immunohematology Diagnostic Devices and Equipment: Blood Typing Systems, Crossmatching Systems, Antibody Screening Systems, Blood Bank Analyzers

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=13065&type=smp

Who Are the Key Players Shaping the In Vitro Diagnostics Market's Competitive Landscape?
Major companies operating in the in vitro diagnostics market include Siemens Healthineers, F. Hoffmann-La Roche AG, Danaher Corporation, Abbott Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Alere Inc., Arkray Inc., Becton, Dickinson and Company (BD), Bio-Rad Laboratories Inc., bioMérieux SA, Grifols SA, Hologic Inc., Werfen SA, Laboratory Corporation, Luminex Corporation, Ortho Clinical Diagnostics, PerkinElmer Inc., Qiagen NV, Quest Diagnostics Inc., QuidelOrtho Corporation, Sysmex Corporation, Illumina Inc., Menarini Silicon Biosystems SPA, SpeeDx Pty. Ltd., GENSPEED Biotech GmbH, Accelerate Diagnostics Inc., Merck KGaA, Caris Life Sciences Inc., Bio-Techne Corporation, Myriad Genetics Inc., Genomic Health Inc., Exact Sciences Crop., Natera Inc., Invitae Crop., Veracyte Inc.

What Geographic Markets Are Powering Growth in the In Vitro Diagnostics Market?
North America was the largest region in the global in-vitro diagnostics market in 2023. Asia-Pacific was the second largest region in the global in-vitro diagnostics market. The regions covered in the in-vitro diagnostics devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13065

"This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work."

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.